Natco Pharma Limited

NATCOPHARM

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 2026597

    Quarter₹ croreYoY
    Jun 20241,237+18.0%
    Sept 20241,293+38.9%
    Dec 2024408-34.8%
    Mar 20251,157+20.0%
    Jun 20251,193-3.6%
    Sept 20251,264-2.2%
    Dec 2025529+29.7%
    Mar 2026609-47.4%
    Jun 2026597-50.0%
  • ₹ crore

    Jun 202648

    Quarter₹ crore
    Jun 202440
    Sept 202451
    Dec 2024168
    Mar 202562
    Jun 202560
    Sept 202593
    Dec 202555
    Mar 202673
    Jun 202648
  • ₹ crore

    Jun 2026645

    Quarter₹ crore
    Jun 20241,277
    Sept 20241,344
    Dec 2024576
    Mar 20251,220
    Jun 20251,252
    Sept 20251,358
    Dec 2025584
    Mar 2026682
    Jun 2026645
  • Cost structure
  • ₹ crore

    Jun 2026151

    Quarter₹ crore
    Jun 2024120
    Sept 2024133
    Dec 2024124
    Mar 2025139
    Jun 2025144
    Sept 2025179
    Dec 2025137
    Mar 2026133
    Jun 2026151
  • ₹ crore

    Jun 2026543

    Quarter₹ crore
    Jun 2024519
    Sept 2024547
    Dec 2024425
    Mar 2025699
    Jun 2025709
    Sept 2025772
    Dec 2025459
    Mar 2026572
    Jun 2026543
  • Exceptional items and tax
  • ₹ crore

    Jun 2026102

    Quarter₹ crore
    Jun 2024758
    Sept 2024797
    Dec 2024150
    Mar 2025521
    Jun 2025543
    Sept 2025586
    Dec 2025125
    Mar 2026110
    Jun 2026102
  • ₹ crore

    Jun 202627

    Quarter₹ crore
    Jun 2024122
    Sept 2024136
    Dec 202425
    Mar 202593
    Jun 202579
    Sept 202585
    Dec 202518
    Mar 2026-100
    Jun 202627
  • Profit
  • ₹ crore

    Jun 202675

    Quarter₹ croreYoY
    Jun 2024636+57.0%
    Sept 2024661+83.5%
    Dec 2024125-34.9%
    Mar 2025428+22.6%
    Jun 2025464-27.1%
    Sept 2025501-24.2%
    Dec 2025107-14.4%
    Mar 2026210-51.0%
    Jun 202675-83.9%
  • Per share
  • ₹ per share

    Jun 20264.17

    Quarter₹ per share
    Jun 202435.53
    Sept 202436.91
    Dec 20246.97
    Mar 202523.90
    Jun 202525.91
    Sept 202527.97
    Dec 20255.97
    Mar 202611.70
    Jun 20264.17
  • Leverage
  • Debt to equity

    times

    Jun 20240.00x

    Quartertimes
    Jun 20240.00x
    Sept 2024—
    Dec 2024—
    Mar 2025—
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
1,2371,2934081,1571,1931,264529609597
Revenue YoY+18.0%+38.9%-34.8%+20.0%-3.6%-2.2%+29.7%-47.4%-50.0%
4051168626093557348
1,2771,3445761,2201,2521,358584682645
Cost structure
120133124139144179137133151
519547425699709772459572543
Exceptional items and tax
758797150521543586125110102
1221362593798518-10027
Profit
63666112542846450110721075
Net profit YoY+57.0%+83.5%-34.9%+22.6%-27.1%-24.2%-14.4%-51.0%-83.9%
Per share
35.5336.916.9723.9025.9127.975.9711.704.17
Leverage
Debt to equity0.00x————————

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.